An Update on CFTR Drug Discovery: Opportunities and Challenges

Pasqualina D'Ursi; Paola Fossa

doi:10.3390/biom12060792

An Update on CFTR Drug Discovery: Opportunities and Challenges

Biomolecules. 2022 Jun 6;12(6):792. doi: 10.3390/biom12060792.

Authors

Pasqualina D'Ursi¹, Paola Fossa²

Affiliations

¹ Institute for Biomedical Technologies, National Research Council (ITB-CNR), 20090 Segrate, Italy.
² Department of Pharmacy, Section of Medicinal Chemistry, School of Medical and Pharmaceutical Sciences, University of Genova, 16148 Genova, Italy.

Abstract

The Biomolecules Special issue on "An Update on CFTR Drug Discovery: Opportunities and Challenges" includes three original research articles and a webinar session focusing on some recent findings concerning CFTR drug discovery [...].

Publication types

Editorial

MeSH terms

Cystic Fibrosis Transmembrane Conductance Regulator* / genetics
Cystic Fibrosis* / drug therapy
Cystic Fibrosis* / genetics
Drug Discovery
Humans
Mutation

Substances

CFTR protein, human
Cystic Fibrosis Transmembrane Conductance Regulator